In particular, we wondered whether the site of antigen delivery would affect the nature and the quality of the immune response and whether this method of targeting the skin's APCs would be capable of inducing CD8 T cell responses to a conventional inactivated influenza vaccine designed to induce vaccine-specific antibodies. The gene discussed is CD8A; the disease is influenza.